We have developed strong collaborations for the study of some important cancer-causing infections in Uganda.

These infections include:

  • Human papillomavirus (HPV)
  • Helicobacter pylori
  • Hepatitis Viruses

Much of this work has evolved into larger multi-country investigations.

We are examining:

  • uptake of HPV vaccination and early impact on circulating HPV subtypes;
  • characterization of H. pylori, patterns of drug resistance and associations with gastric abnormalities with a view to developing prevention trials in the future and; 
  • progression of Hepatitis B Virus-related liver disease and the contribution of infection to the total burden of abnormal liver function.

Publications

Thirteen cancers associated with HIV infection in a Black South African cancer patient population (1995-2016), International Journal of Cancer. 2023

Usefulness of high-risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta-analysisJournal of Medical Virology, 2023

HPV types 16/18 L1 E6 and E7 proteins seropositivity and cervical cancer risk in HIV-positive and HIV-negative black South African womenInfectious Agents and Cancer, 2022

Ranking lifestyle risk factors for cervical cancer among Black women: A case-control study from Johannesburg, South Africa, PLOS ONE, 2021

Contact us

Helen Cohen
ECSG Research Administrator

helen.cohen@york.ac.uk
+44 (0)1904 32 1927
Seebohm Rowntree Building, University of York, UK, YO10 5DD
Twitter

Contact us

Helen Cohen
ECSG Research Administrator

helen.cohen@york.ac.uk
+44 (0)1904 32 1927
Seebohm Rowntree Building, University of York, UK, YO10 5DD
Twitter